Cleaved form of osteopontin in urine as a clinical marker of lupus nephritis

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Kitagori, Koji ^a   Yoshifuji, Hajime ^a   Oku, Takuma ^a,b   Sasaki, Chiyomi ^a,b   Miyata, Hitomi ^a   Mori, Keita P ^a   Nakajima, Toshiki ^a   Ohmura, Koichiro ^a   Kawabata, Daisuke ^a   Yukawa, Naoichiro ^a,c   Imura, Yoshitaka ^a   Murakami, Kosaku ^a   Nakashima, Ran ^a   Usui, Takashi ^a   Fujii, Takao ^a,c   Sakai, Kaoru ^a   Yanagita, Motoko ^a   Hirayama, Yoshitaka ^a,b   Mimori, Tsuneyo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALBINDIN; CLUSTERIN; CYSTATIN C; GLUCOCORTICOID; GLUTATHIONE TRANSFERASE P1; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOPONTIN; OSTEOPONTIN N HALF; STROMELYSIN; THROMBIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; OSTEOPONTIN (1-168), HUMAN; PEPTIDE FRAGMENT; SPP1 PROTEIN, HUMAN;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ACTIVITY; DISEASE MARKER; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MINIMAL CHANGE NEPHROTIC SYNDROME; MOLECULAR DYNAMICS; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN CREATININE RATIO; PROTEIN FUNCTION; PROTEIN URINE LEVEL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; AGED; BLOOD; COMPLICATION; LIPOID NEPHROSIS; LUPUS NEPHRITIS; METABOLISM; MIDDLE AGED; URINE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; OSTEOPONTIN; PEPTIDE FRAGMENTS; THROMBIN; YOUNG ADULT;

EID: 85006892914     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0167141     Document Type: Article

References (29)

1. Ikeuchi H, Hiromura K, Kayakabe K, Tshilela KA, Uchiyama K, Hamatani H, et al. Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III/IV + V): A long-term observational study. Mod Rheumatol. 2016;:1-6.
2. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J. 1993; 7(15):1475-82. PMID: 8262332
3. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, et al. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res. 1998; 13(7):1101-11. doi: 10.1359/jbmr.1998.13.7.1101 PMID: 9661074
4. Ihara H, Denhardt DT, Furuya K, Yamashita T, Muguruma Y, Tsuji K, et al. Parathyroid hormoneinduced bone resorption does not occur in the absence of osteopontin. J Biol Chem. 2001; 276 (16):13065-71. doi: 10.1074/jbc.M010938200 PMID: 11278791
5. Yamamoto S, Nasu K, Ishida T, Setoguchi M, Higuchi Y, Hijiya N, et al. Effect of recombinant osteopontin on adhesion and migration of P388D1 cells. Ann N Y Acad Sci. 1995; 760:378-80. PMID: 7785922
6. O'Regan AW, Chupp GL, Lowry JA, Goetschkes M, Mulligan N, Berman JS. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J Immunol. 1999; 162(2):1024-31. PMID: 9916729
7. Tahir S, Fukushima Y, Sakamoto K, Sato K, Fujita H, Inoue J, et al. A CD153+CD4+ T follicular cell population with cell-senescence features plays a crucial role in lupus pathogenesis via osteopontin production. J Immunol. 2015; 194(12):5725-35. doi: 10.4049/jimmunol.1500319 PMID: 25972477
8. Okada H, Moriwaki K, Konishi K, Kobayashi T, Sugahara S, Nakamoto H, et al. Tubular osteopontin expression in human glomerulonephritis and renal vasculitis. Am J Kidney Dis. 2000; 36(3):498-506. doi: 10.1053/ajkd.2000.9790 PMID: 10977781
9. Wong CK, Lit LC, Tam LS, Li EK, Lam CW. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005; 44 (5):602-6.
10. Qiong L, Xiang-pei, Bai H, Long Q, Xiwo-mei L, Hong Z. Detection of osteopontin in sera, urine and renal tissue in patients with systemic lupus erythematosus and its significance. Chin J Dermatol. 2010; 43(No.1).
11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25(11):1271-7. PMID: 7138600
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9):1725.
13. Cornell LD. IgA nephropathy. In: Colvin RB, editors. DIAGNOSTIC PATHOLOGY KIDNEY DISEASE 1st.ed.: Amirsys; 2011.P2.142-155.
14. Hertig A, Rondeau E. Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury. J Am Soc Nephrol. 2004; 15(4):844-53. PMID: 15034086
15. Kitamoto Y, Tomita K, Imamura T. Assessment of thrombin in the urine of glomerulonephritic patients by enzyme-linked immunosorbent assay. Ann Clin Biochem. 2004; 41(Pt 2):133-7. doi: 10.1258/000456304322880023 PMID: 15025804
16. Gang X, Ueki K, Kon S, Maeda M, Naruse T, Nojima Y. Reduced urinary excretion of intact osteopontin in patients with IgA nephropathy. Am J Kidney Dis. 2001; 37(2):374-9. doi: 10.1053/ajkd.2001.21316 PMID: 11157380
17. Naito T, Razzaque MS, Nazneen A, Liu D, Nihei H, Koji T, et al. Renal expression of the Ets-1 protooncogene during progression of rat crescentic glomerulonephritis. J Am Soc Nephrol. 2000; 11 (12):2243-55. PMID: 11095647
18. Agnihotri R, Crawford HC, Haro H, Matrisian LM, Havrda MC, Liaw L. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem. 2001; 276(30):28261-7. doi: 10.1074/jbc.M103608200 PMID: 11375993
19. Smith LL, Cheung HK, Ling LE, Chen J, Sheppard D, Pytela R, et al. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin. J Biol Chem. 1996; 271 (45):28485-91. PMID: 8910476
20. Kon S, Ikesue M, Kimura C, Aoki M, Nakayama Y, Saito Y, et al. Syndecan-4 protects against osteopontin- mediated acute hepatic injury by masking functional domains of osteopontin. J Exp Med. 2008; 205(1):25-33. doi: 10.1084/jem.20071324 PMID: 18158320
21. Rullo OJ, Woo JM, Parsa MF, Hoftman AD, Maranian P, Elashoff DA, et al. Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus. Arthritis Res Ther. 2013; 15(1):R18. doi: 10.1186/ar4150 PMID: 23343383
22. Patarca R, Freeman GJ, Singh RP, Wei FY, Durfee T, Blattner F, et al. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med. 1989; 170(1):145-61. PMID: 2787378
23. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 2000; 287(5454):860-4. PMID: 10657301
24. Denhardt DT, Noda M. Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl. 1998; 30-31:92-102. PMID: 9893260
25. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004; 65(2):521-30. doi: 10. 1111/j.1523-1755.2004.00443.x PMID: 14717922
26. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004; 15(2):241-50. PMID: 14747370
27. Yamaguchi H, Igarashi M, Hirata A, Tsuchiya H, Sugiyama K, Morita Y, et al. Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients. Endocr J. 2004; 51 (5):499-504. PMID: 15516785
28. Daniel V, Trautmann Y, Konrad M, Nayir A, Scharer K. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol. 1997; 47 (5):289-97. PMID: 9181275
29. Sahali D, Pawlak A, Valanciute A, Grimbert P, Lang P, Remy P, et al. A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol. 2002; 13(5):1238-47. PMID: 11961011